The differential roles of Slit2-exon 15 splicing variants in angiogenesis and HUVEC permeability

Angiogenesis

Volumn 18, Issue 3, 2015, Pages 301-312

  Yang, Yun Chiu ^a   Chen, Pei Ni ^b   Wang, Siou Yu ^b   Liao, Chen Yi ^b   Lin, Yu Ying ^b   Sun, Shih Rhong ^b   Chiu, Chun Ling ^b   Hsieh, Yih Shou ^b   Shieh, Jia Ching ^b   Chang, Jinghua Tsai ^b,c  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Chicken chorioallantoic membrane assay; Human umbilical vein endothelial cells; Permeability; Robo1; Robo4; Slit2 splicing variants; Tube formation

Indexed keywords

ROBO1 PROTEIN; ROBO4 PROTEIN; SLIT2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CONDITIONED MEDIUM; IMMUNOGLOBULIN RECEPTOR; NERVE PROTEIN; ROBO4 PROTEIN, HUMAN; ROUNDABOUT RECEPTOR; SIGNAL PEPTIDE; SLIT HOMOLOG 2 PROTEIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CANCER CELL; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL MOTILITY; CHORIOALLANTOIS; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SPLICING; ENDOTHELIUM CELL; EXON; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; ALTERNATIVE RNA SPLICING; ANIMAL; CELL MOTION; CHICK EMBRYO; CONDITIONED MEDIUM; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PERMEABILITY; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; CELL MOVEMENT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CULTURE MEDIA, CONDITIONED; EXONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PERMEABILITY; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84931564106     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-015-9467-4     Document Type: Article

References (39)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
2. Jayson GC, Hicklin DJ, Ellis LM (2012) Antiangiogenic therapy—evolving view based on clinical trial results. Nat Rev Clin Oncol 9(5):297–303
3. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298–307
4. Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev 8(8):592–603
5. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706):58–62
6. Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER, Latif F (2002) SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62(20):5874–5880
7. Dallol A, Morton D, Maher ER, Latif F (2003) SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 63(5):1054–1058
8. Kim HK, Zhang H, Li H, Wu TT, Swisher S, He D, Wu L, Xu J, Elmets CA, Athar M, Xu XC, Xu H (2008) Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. Neoplasia 10(12):1411–1420
9. Mertsch S, Schmitz N, Jeibmann A, Geng JG, Paulus W, Senner V (2008) Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol 87(1):1–7
10. Werbowetski-Ogilvie TE, Seyed Sadr M, Jabado N, Angers-Loustau A, Agar NY, Wu J, Bjerkvig R, Antel JP, Faury D, Rao Y, Del Maestro RF (2006) Inhibition of medulloblastoma cell invasion by slit. Oncogene 25(37):5103–5112
11. Yiin JJ, Hu B, Jarzynka MJ, Feng H, Liu KW, Wu JY, Ma HI, Cheng SY (2009) Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro-oncology 11(6):779–789
12. Kaur S, Castellone MD, Bedell VM, Konar M, Gutkind JS, Ramchandran R (2006) Robo4 signaling in endothelial cells implies attraction guidance mechanisms. J Biol Chem 281(16):11347–11356
13. Kaur S, Samant GV, Pramanik K, Loscombe PW, Pendrak ML, Roberts DD, Ramchandran R (2008) Silencing of directional migration in roundabout4 knockdown endothelial cells. BMC Cell Biol 9:61
14. Sheldon H, Andre M, Legg JA, Heal P, Herbert JM, Sainson R, Sharma AS, Kitajewski JK, Heath VL, Bicknell R (2009) Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors. Faseb J 23(2):513–522
15. Urbich C, Rossig L, Kaluza D, Potente M, Boeckel JN, Knau A, Diehl F, Geng JG, Hofmann WK, Zeiher AM, Dimmeler S (2009) HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. Blood 113(22):5669–5679
16. Yang XM, Han HX, Sui F, Dai YM, Chen M, Geng JG (2010) Slit–Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis. Biochem Biophys Res Commun 396(2):571–577
17. Han X, Zhang MC (2010) Potential anti-angiogenic role of Slit2 in corneal neovascularization. Exp Eye Res 90(6):742–749
18. Liu D, Hou J, Hu X, Wang X, Xiao Y, Mou Y, De Leon H (2006) Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation. Circ Res 98(4):480–489
19. Park KW, Morrison CM, Sorensen LK, Jones CA, Rao Y, Chien CB, Wu JY, Urness LD, Li DY (2003) Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol 261(1):251–267
20. Howitt JA, Clout NJ, Hohenester E (2004) Binding site for Robo receptors revealed by dissection of the leucine-rich repeat region of Slit. EMBO J 23(22):4406–4412
21. Liu Z, Patel K, Schmidt H, Andrews W, Pini A, Sundaresan V (2004) Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. Mol Cell Neurosci 26(2):232–240
22. Morlot C, Hemrika W, Romijn RA, Gros P, Cusack S, McCarthy AA (2007) Production of Slit2 LRR domains in mammalian cells for structural studies and the structure of human Slit2 domain 3. Acta Crystallogr A 63(Pt 9):961–968
23. Lin YY, Yang CH, Sheu GT, Huang CY, Wu YC, Chuang SM, Fann MJ, Chang H, Lee H, Chang JT (2011) A novel exon 15-deleted, splicing variant of Slit2 shows potential for growth inhibition in addition to invasion inhibition in lung cancer. Cancer 117(15):3404–3415
24. Jones CA, London NR, Chen H, Park KW, Sauvaget D, Stockton RA, Wythe JD, Suh W, Larrieu-Lahargue F, Mukouyama YS, Lindblom P, Seth P, Frias A, Nishiya N, Ginsberg MH, Gerhardt H, Zhang K, Li DY (2008) Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 14(4):448–453
25. Jones CA, Nishiya N, London NR, Zhu W, Sorensen LK, Chan AC, Lim CJ, Chen H, Zhang Q, Schultz PG, Hayallah AM, Thomas KR, Famulok M, Zhang K, Ginsberg MH, Li DY (2009) Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat Cell Biol 11(11):1325–1331
26. Dejana E (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5(4):261–270. doi:10.1038/nrm1357
27. Alghisi GC, Ponsonnet L, Ruegg C (2009) The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One 4(2):e4449. doi:10.1371/journal.pone.0004449
28. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev 1(1):46–54
29. Wiseman BS, Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296(5570):1046–1049
30. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91(3):1071–1121
31. Ballard MS, Hinck L (2012) A roundabout way to cancer. Adv Cancer Res 114:187–235. doi:10.1016/B978-0-12-386503-8.00005-3
32. Wang B, Xiao Y, Ding BB, Zhang N, Yuan X, Gui L, Qian KX, Duan S, Chen Z, Rao Y, Geng JG (2003) Induction of tumor angiogenesis by Slit–Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 4(1):19–29
33. Morlot C, Thielens NM, Ravelli RB, Hemrika W, Romijn RA, Gros P, Cusack S, McCarthy AA (2007) Structural insights into the Slit–Robo complex. Proc Natl Acad Sci USA 104(38):14923–14928. doi:10.1073/pnas.0705310104
34. Zhang B, Dietrich UM, Geng JG, Bicknell R, Esko JD, Wang L (2009) Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood 114(19):4300–4309. doi:10.1182/blood-2008-12-193326
35. Suchting S, Heal P, Tahtis K, Stewart LM, Bicknell R (2005) Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration. FASEB J 19(1):121–123. doi:10.1096/fj.04-1991fje
36. Steigemann P, Molitor A, Fellert S, Jackle H, Vorbruggen G (2004) Heparan sulfate proteoglycan syndecan promotes axonal and myotube guidance by slit/robo signaling. Curr Biol 14(3):225–230. doi:10.1016/j.cub.2004.01.006
37. Hu H (2001) Cell-surface heparan sulfate is involved in the repulsive guidance activities of Slit2 protein. Nat Neurosci 4(7):695–701. doi:10.1038/89482
38. Marlow R, Binnewies M, Sorensen LK, Monica SD, Strickland P, Forsberg EC, Li DY, Hinck L (2010) Vascular Robo4 restricts proangiogenic VEGF signaling in breast. Proc Natl Acad Sci USA 107(23):10520–10525. doi:10.1073/pnas.1001896107
39. Shang B, Cao Z, Zhou Q (2012) Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives. Front Med 6(1):67–78. doi:10.1007/s11684-012-0176-8